- Home
- INSG vs COYA Comparison
INSG vs COYA Comparison
Compare INSG & COYA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INSG
- COYA
- Stock Information
- Founded
- INSG 1996
- COYA 2020
- Country
- INSG United States
- COYA United States
- Employees
- INSG N/A
- COYA N/A
- Industry
- INSG Telecommunications Equipment
- COYA Biotechnology: Pharmaceutical Preparations
- Sector
- INSG Telecommunications
- COYA Health Care
- Exchange
- INSG Nasdaq
- COYA Nasdaq
- Market Cap
- INSG 110.6M
- COYA 99.8M
- IPO Year
- INSG 2000
- COYA 2022
- Fundamental
- Price
- INSG $7.67
- COYA $6.11
- Analyst Decision
- INSG Buy
- COYA Strong Buy
- Analyst Count
- INSG 3
- COYA 4
- Target Price
- INSG $13.00
- COYA $16.50
- AVG Volume (30 Days)
- INSG 226.7K
- COYA 65.9K
- Earning Date
- INSG 08-06-2025
- COYA 08-11-2025
- Dividend Yield
- INSG N/A
- COYA N/A
- EPS Growth
- INSG N/A
- COYA N/A
- EPS
- INSG 0.31
- COYA N/A
- Revenue
- INSG $185,412,000.00
- COYA $3,685,107.00
- Revenue This Year
- INSG N/A
- COYA $106.97
- Revenue Next Year
- INSG $14.39
- COYA N/A
- P/E Ratio
- INSG $24.70
- COYA N/A
- Revenue Growth
- INSG 20.40
- COYA N/A
- 52 Week Low
- INSG $6.24
- COYA $4.65
- 52 Week High
- INSG $20.67
- COYA $10.24
- Technical
- Relative Strength Index (RSI)
- INSG 43.20
- COYA 58.05
- Support Level
- INSG $8.06
- COYA $5.97
- Resistance Level
- INSG $9.07
- COYA $6.45
- Average True Range (ATR)
- INSG 0.44
- COYA 0.34
- MACD
- INSG -0.06
- COYA 0.05
- Stochastic Oscillator
- INSG 3.45
- COYA 64.89
About INSG Inseego Corp.
Inseego Corp is into the design and development of fixed and mobile wireless solutions (4G and 5G NR), Industrial Internet of Things and cloud solutions for enterprises, service providers, small and medium-sized businesses, governments, and consumers around the globe. Its products and services include intelligent mobile hotspots, wireless routers for IoT applications, USB modems, integrated telematics and mobile tracking devices, which are supported by applications software and cloud services designed to enable customers to easily analyze data insights and configure and manage their hardware. It generates maximum revenue from United States and Canada. The company also has a presence in Australia and Europe (including United Kingdom).
About COYA Coya Therapeutics Inc.
Coya Therapeutics Inc is a clinical-stage biotechnology company focused on developing proprietary medicinal products to modulate the function of regulatory T cells. It is developing its multi-modality Treg therapies for neurodegenerative, autoimmune, and metabolic diseases.